世界のがん支持療法市場 2019年

【英語タイトル】Global Cancer Supportive Care Medicine Market Professional Survey Report 2019

QYResearchが出版した調査資料(DATA909X04994)・商品コード:DATA909X04994
・発行会社(調査会社):QYResearch
・発行日:2019年11月15日(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥511,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥766,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,022,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、がん支持療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、制吐薬、エリスロポエチン刺激剤、顆粒球刺激剤、鎮痛剤、その他に、用途別には、化学療法による貧血、CINV、骨転移、がん性疼痛、その他にセグメント区分し、がん支持療法の世界市場を分析しました。


・エグゼクティブ・サマリー
・がん支持療法の世界市場概要
・がん支持療法の製造コスト構成分析
・がん支持療法の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・がん支持療法の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・がん支持療法のセグメント分析(種類別)
(制吐薬、エリスロポエチン刺激剤、顆粒球刺激剤、鎮痛剤、その他)
・がん支持療法のセグメント分析(用途別)
(化学療法による貧血、CINV、骨転移、がん性疼痛、その他)
・がん支持療法の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Amgen、Helsinn Healthcare、Johnson &Johnson、Merck、F. Hoffmann-La Roche、GlaxoSmithKline、Heron Therapeutics、Kyowa Hakko Kirin、Novartis、TESARO、Teva Pharmaceutical Industries、)
・がん支持療法の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Cancer Supportive Care Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Cancer Supportive Care Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Supportive Care Medicine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Supportive Care Medicine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer Supportive Care Medicine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Heron Therapeutics
Kyowa Hakko Kirin
Novartis
TESARO
Teva Pharmaceutical Industries

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Antiemetic Drugs
Erythropoietin-Stimulating Agents
Granulocyte-Stimulating Agents
Analgesics
Others

Segment by Application
Chemotherapy-Induced Anemia
CINV
Bone Metastasis
Cancer Pain
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Cancer Supportive Care Medicine
1.1 Definition of Cancer Supportive Care Medicine
1.2 Cancer Supportive Care Medicine Segment by Type
1.2.1 Global Cancer Supportive Care Medicine Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Antiemetic Drugs
1.2.3 Erythropoietin-Stimulating Agents
1.2.4 Granulocyte-Stimulating Agents
1.2.5 Analgesics
1.2.6 Others
1.3 Cancer Supportive Care Medicine Segment by Applications
1.3.1 Global Cancer Supportive Care Medicine Consumption Comparison by Applications (2014-2025)
1.3.2 Chemotherapy-Induced Anemia
1.3.3 CINV
1.3.4 Bone Metastasis
1.3.5 Cancer Pain
1.3.6 Other
1.4 Global Cancer Supportive Care Medicine Overall Market
1.4.1 Global Cancer Supportive Care Medicine Revenue (2014-2025)
1.4.2 Global Cancer Supportive Care Medicine Production (2014-2025)
1.4.3 North America Cancer Supportive Care Medicine Status and Prospect (2014-2025)
1.4.4 Europe Cancer Supportive Care Medicine Status and Prospect (2014-2025)
1.4.5 China Cancer Supportive Care Medicine Status and Prospect (2014-2025)
1.4.6 Japan Cancer Supportive Care Medicine Status and Prospect (2014-2025)
1.4.7 Southeast Asia Cancer Supportive Care Medicine Status and Prospect (2014-2025)
1.4.8 India Cancer Supportive Care Medicine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine
2.3 Manufacturing Process Analysis of Cancer Supportive Care Medicine
2.4 Industry Chain Structure of Cancer Supportive Care Medicine

3 Development and Manufacturing Plants Analysis of Cancer Supportive Care Medicine
3.1 Capacity and Commercial Production Date
3.2 Global Cancer Supportive Care Medicine Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Cancer Supportive Care Medicine
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Cancer Supportive Care Medicine Production and Capacity Analysis
4.2 Cancer Supportive Care Medicine Revenue Analysis
4.3 Cancer Supportive Care Medicine Price Analysis
4.4 Market Concentration Degree

5 Cancer Supportive Care Medicine Regional Market Analysis
5.1 Cancer Supportive Care Medicine Production by Regions
5.1.1 Global Cancer Supportive Care Medicine Production by Regions
5.1.2 Global Cancer Supportive Care Medicine Revenue by Regions
5.2 Cancer Supportive Care Medicine Consumption by Regions
5.3 North America Cancer Supportive Care Medicine Market Analysis
5.3.1 North America Cancer Supportive Care Medicine Production
5.3.2 North America Cancer Supportive Care Medicine Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Cancer Supportive Care Medicine Import and Export
5.4 Europe Cancer Supportive Care Medicine Market Analysis
5.4.1 Europe Cancer Supportive Care Medicine Production
5.4.2 Europe Cancer Supportive Care Medicine Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Cancer Supportive Care Medicine Import and Export
5.5 China Cancer Supportive Care Medicine Market Analysis
5.5.1 China Cancer Supportive Care Medicine Production
5.5.2 China Cancer Supportive Care Medicine Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Cancer Supportive Care Medicine Import and Export
5.6 Japan Cancer Supportive Care Medicine Market Analysis
5.6.1 Japan Cancer Supportive Care Medicine Production
5.6.2 Japan Cancer Supportive Care Medicine Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Cancer Supportive Care Medicine Import and Export
5.7 Southeast Asia Cancer Supportive Care Medicine Market Analysis
5.7.1 Southeast Asia Cancer Supportive Care Medicine Production
5.7.2 Southeast Asia Cancer Supportive Care Medicine Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Cancer Supportive Care Medicine Import and Export
5.8 India Cancer Supportive Care Medicine Market Analysis
5.8.1 India Cancer Supportive Care Medicine Production
5.8.2 India Cancer Supportive Care Medicine Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Cancer Supportive Care Medicine Import and Export

6 Cancer Supportive Care Medicine Segment Market Analysis (by Type)
6.1 Global Cancer Supportive Care Medicine Production by Type
6.2 Global Cancer Supportive Care Medicine Revenue by Type
6.3 Cancer Supportive Care Medicine Price by Type

7 Cancer Supportive Care Medicine Segment Market Analysis (by Application)
7.1 Global Cancer Supportive Care Medicine Consumption by Application
7.2 Global Cancer Supportive Care Medicine Consumption Market Share by Application (2014-2019)

8 Cancer Supportive Care Medicine Major Manufacturers Analysis
8.1 Amgen
8.1.1 Amgen Cancer Supportive Care Medicine Production Sites and Area Served
8.1.2 Amgen Product Introduction, Application and Specification
8.1.3 Amgen Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Helsinn Healthcare
8.2.1 Helsinn Healthcare Cancer Supportive Care Medicine Production Sites and Area Served
8.2.2 Helsinn Healthcare Product Introduction, Application and Specification
8.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Johnson &Johnson
8.3.1 Johnson &Johnson Cancer Supportive Care Medicine Production Sites and Area Served
8.3.2 Johnson &Johnson Product Introduction, Application and Specification
8.3.3 Johnson &Johnson Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Merck
8.4.1 Merck Cancer Supportive Care Medicine Production Sites and Area Served
8.4.2 Merck Product Introduction, Application and Specification
8.4.3 Merck Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 F. Hoffmann-La Roche
8.5.1 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Sites and Area Served
8.5.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Cancer Supportive Care Medicine Production Sites and Area Served
8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
8.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Heron Therapeutics
8.7.1 Heron Therapeutics Cancer Supportive Care Medicine Production Sites and Area Served
8.7.2 Heron Therapeutics Product Introduction, Application and Specification
8.7.3 Heron Therapeutics Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Kyowa Hakko Kirin
8.8.1 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Sites and Area Served
8.8.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
8.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Novartis
8.9.1 Novartis Cancer Supportive Care Medicine Production Sites and Area Served
8.9.2 Novartis Product Introduction, Application and Specification
8.9.3 Novartis Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 TESARO
8.10.1 TESARO Cancer Supportive Care Medicine Production Sites and Area Served
8.10.2 TESARO Product Introduction, Application and Specification
8.10.3 TESARO Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Teva Pharmaceutical Industries

9 Development Trend of Analysis of Cancer Supportive Care Medicine Market
9.1 Global Cancer Supportive Care Medicine Market Trend Analysis
9.1.1 Global Cancer Supportive Care Medicine Market Size (Volume and Value) Forecast 2019-2025
9.2 Cancer Supportive Care Medicine Regional Market Trend
9.2.1 North America Cancer Supportive Care Medicine Forecast 2019-2025
9.2.2 Europe Cancer Supportive Care Medicine Forecast 2019-2025
9.2.3 China Cancer Supportive Care Medicine Forecast 2019-2025
9.2.4 Japan Cancer Supportive Care Medicine Forecast 2019-2025
9.2.5 Southeast Asia Cancer Supportive Care Medicine Forecast 2019-2025
9.2.6 India Cancer Supportive Care Medicine Forecast 2019-2025
9.3 Cancer Supportive Care Medicine Market Trend (Product Type)
9.4 Cancer Supportive Care Medicine Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Cancer Supportive Care Medicine Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Cancer Supportive Care Medicine
Table Global Cancer Supportive Care Medicine Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Cancer Supportive Care Medicine Production Market Share by Types in 2018
Figure Antiemetic Drugs Product Picture
Figure Erythropoietin-Stimulating Agents Product Picture
Figure Granulocyte-Stimulating Agents Product Picture
Figure Analgesics Product Picture
Figure Others Product Picture
Table Global Cancer Supportive Care Medicine Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Cancer Supportive Care Medicine Consumption Market Share by Applications in 2018
Figure Chemotherapy-Induced Anemia
Figure CINV
Figure Bone Metastasis
Figure Cancer Pain
Figure Other
Figure Global Cancer Supportive Care Medicine Revenue (Million USD) (2014-2025)
Figure Global Cancer Supportive Care Medicine Production (K Units) (2014-2025)
Figure North America Cancer Supportive Care Medicine Market Size (Million USD) (2014-2025)
Figure Europe Cancer Supportive Care Medicine Market Size (Million USD) (2014-2025)
Figure China Cancer Supportive Care Medicine Market Size (Million USD) (2014-2025)
Figure Japan Cancer Supportive Care Medicine Market Size (Million USD) (2014-2025)
Figure Southeast Asia Cancer Supportive Care Medicine Market Size (Million USD) (2014-2025)
Figure India Cancer Supportive Care Medicine Market Size (Million USD) (2014-2025)
Table Cancer Supportive Care Medicine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine in 2018
Figure Manufacturing Process Analysis of Cancer Supportive Care Medicine
Figure Industry Chain Structure of Cancer Supportive Care Medicine
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Cancer Supportive Care Medicine Manufacturing Plants Distribution
Table Cancer Supportive Care Medicine Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Cancer Supportive Care Medicine Capacity (K Units) of Major Manufacturers (2014-2019)
Table Cancer Supportive Care Medicine Production (K Units) of Major Manufacturers (2014-2019)
Table Cancer Supportive Care Medicine Production Market Share of Major Manufacturers (2014-2019)
Figure Cancer Supportive Care Medicine Production Share by Manufacturers in 2018
Table Cancer Supportive Care Medicine Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Cancer Supportive Care Medicine Revenue Market Share of Major Manufacturers (2014-2019)
Figure Cancer Supportive Care Medicine Revenue Share by Manufacturers in 2018
Table Cancer Supportive Care Medicine Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Cancer Supportive Care Medicine Production by Regions 2014-2019 (K Units)
Table Global Cancer Supportive Care Medicine Production Market Share by Regions 2014-2019
Figure Global Cancer Supportive Care Medicine Production Market Share by Regions in 2018
Table Global Cancer Supportive Care Medicine Revenue by Regions 2014-2019 (Million USD)
Table Global Cancer Supportive Care Medicine Revenue Market Share by Regions 2014-2019
Figure Global Cancer Supportive Care Medicine Revenue Market Share by Regions in 2018
Table Global Cancer Supportive Care Medicine Consumption by Regions 2014-2019 (K Units)
Table Global Cancer Supportive Care Medicine Consumption Market Share by Regions 2014-2019
Figure North America Cancer Supportive Care Medicine Production Growth Rate 2014-2019 (K Units)
Figure North America Cancer Supportive Care Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table North America Cancer Supportive Care Medicine Production, Consumption Import and Export (K Units)
Figure Europe Cancer Supportive Care Medicine Production Growth Rate 2014-2019 (K Units)
Figure Europe Cancer Supportive Care Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Cancer Supportive Care Medicine Production, Consumption Import and Export (K Units)
Figure China Cancer Supportive Care Medicine Production Growth Rate 2014-2019 (K Units)
Figure China Cancer Supportive Care Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table China Cancer Supportive Care Medicine Production, Consumption Import and Export (K Units)
Figure Japan Cancer Supportive Care Medicine Production Growth Rate 2014-2019 (K Units)
Figure Japan Cancer Supportive Care Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Cancer Supportive Care Medicine Production, Consumption Import and Export (K Units)
Figure Southeast Asia Cancer Supportive Care Medicine Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Cancer Supportive Care Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Cancer Supportive Care Medicine Production, Consumption Import and Export (K Units)
Figure India Cancer Supportive Care Medicine Production Growth Rate 2014-2019 (K Units)
Figure India Cancer Supportive Care Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table India Cancer Supportive Care Medicine Production, Consumption Import and Export (K Units)
Figure Global Consumption Cancer Supportive Care Medicine Market Share by Application (2014-2019)
Figure Global Value (Consumption) Cancer Supportive Care Medicine Market Share by Application (2014-2019)
Table Amgen Cancer Supportive Care Medicine Production Sites and Area Served
Table Amgen Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table Amgen Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table Amgen Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure Amgen Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table Amgen Cancer Supportive Care Medicine Main Business and Markets Served
Table Helsinn Healthcare Cancer Supportive Care Medicine Production Sites and Area Served
Table Helsinn Healthcare Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table Helsinn Healthcare Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Helsinn Healthcare Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table Helsinn Healthcare Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table Helsinn Healthcare Cancer Supportive Care Medicine Main Business and Markets Served
Table Johnson &Johnson Cancer Supportive Care Medicine Production Sites and Area Served
Table Johnson &Johnson Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table Johnson &Johnson Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson &Johnson Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table Johnson &Johnson Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure Johnson &Johnson Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table Johnson &Johnson Cancer Supportive Care Medicine Main Business and Markets Served
Table Merck Cancer Supportive Care Medicine Production Sites and Area Served
Table Merck Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table Merck Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table Merck Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure Merck Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table Merck Cancer Supportive Care Medicine Main Business and Markets Served
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Sites and Area Served
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Main Business and Markets Served
Table GlaxoSmithKline Cancer Supportive Care Medicine Production Sites and Area Served
Table GlaxoSmithKline Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table GlaxoSmithKline Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table GlaxoSmithKline Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table GlaxoSmithKline Cancer Supportive Care Medicine Main Business and Markets Served
Table Heron Therapeutics Cancer Supportive Care Medicine Production Sites and Area Served
Table Heron Therapeutics Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table Heron Therapeutics Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Heron Therapeutics Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table Heron Therapeutics Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure Heron Therapeutics Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table Heron Therapeutics Cancer Supportive Care Medicine Main Business and Markets Served
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Sites and Area Served
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Main Business and Markets Served
Table Novartis Cancer Supportive Care Medicine Production Sites and Area Served
Table Novartis Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table Novartis Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table Novartis Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure Novartis Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table Novartis Cancer Supportive Care Medicine Main Business and Markets Served
Table TESARO Cancer Supportive Care Medicine Production Sites and Area Served
Table TESARO Cancer Supportive Care Medicine Product Introduction, Application and Specification
Table TESARO Cancer Supportive Care Medicine Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table TESARO Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
Table TESARO Cancer Supportive Care Medicine Production Market Share (2014-2019)
Figure TESARO Cancer Supportive Care Medicine Revenue Market Share (2014-2019)
Table TESARO Cancer Supportive Care Medicine Main Business and Markets Served
Table Teva Pharmaceutical Industries Cancer Supportive Care Medicine Production Sites and Area Served
Figure Global Cancer Supportive Care Medicine Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Cancer Supportive Care Medicine Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Cancer Supportive Care Medicine Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Cancer Supportive Care Medicine Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Cancer Supportive Care Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Cancer Supportive Care Medicine Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Cancer Supportive Care Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Cancer Supportive Care Medicine Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Cancer Supportive Care Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Cancer Supportive Care Medicine Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Cancer Supportive Care Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Cancer Supportive Care Medicine Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Cancer Supportive Care Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Cancer Supportive Care Medicine Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Cancer Supportive Care Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Cancer Supportive Care Medicine by Type (2019-2025)
Table Global Consumption (K Units) of Cancer Supportive Care Medicine by Application (2019-2025)
Table Cancer Supportive Care Medicine Distributors List
Table Cancer Supportive Care Medicine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Amgen、Helsinn Healthcare、Johnson &Johnson、Merck、F. Hoffmann-La Roche、GlaxoSmithKline、Heron Therapeutics、Kyowa Hakko Kirin、Novartis、TESARO、Teva Pharmaceutical Industries、

★調査レポート[世界のがん支持療法市場 2019年] (コード:DATA909X04994)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のがん支持療法市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆